EVEROLIMUS Zentiva cpr 10 mg 30 pce
7680680000038
CH-68000
L01EG02
07.16.4.
Reimbursement limitations:
EVEROLIMUSZE
Traitement des patients atteints d'un carcinome à cellules rénales avancé après échec d'un traitement par …
1 / 3
google
Details
- Product number
- 6800003
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- everolimusum 10 mg, E 321, hypromellosum, lactosum 272 mg, lactosum monohydricum 25 mg, crospovidonum, magnesii stearas, pro compresso.
Articles (1)
Everolimus Zentiva 10 mg, Tabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | ANTOX |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
272.0 MG | Substance | HBESI |
|
(N/A)
|
25.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1330.85
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/08/2024
Authorization holder
Helvepharm AG
8500 Frauenfeld
Authorization information
- Swissmedic authorization number
- 68000
- Drug name
- Everolimus Zentiva, Tabletten
- Galenic form
- TAB
- ATC Code
- L01EG02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 20/05/2021
- Authorization expiration date
- 19/05/2026
- IT number
- 07.16.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- EVEROLIMUS Zentiva cpr 10 mg 30 pce
- Description (DE)
- EVEROLIMUS Zentiva Tabl 10 mg 30 Stk
- Market launch
- 20/05/2021
- Narcotic (BTM)
- No